Page last updated: 2024-09-04

levofloxacin and Experimental Lung Inflammation

levofloxacin has been researched along with Experimental Lung Inflammation in 92 studies

Research

Studies (92)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (4.35)	18.2507
2000's	41 (44.57)	29.6817
2010's	39 (42.39)	24.3611
2020's	8 (8.70)	2.80

Authors

Authors	Studies
Drusano, GL; Fregeau, C; Kulawy, R; Liu, W; Louie, A	1
Banevicius, MA; Crandon, JL; Koomanachai, P; Nicolau, DP; Peng, L	1
Chen, Q; Fan, X; Guo, YL; Li, Q; Lv, XT; Zhao, C	1
Chi, Z; Pan, X; Tang, W; Yin, Y; Zhao, M	1
Cheong, HJ; Hyun, H; Kim, WJ; Noh, JY; Seong, H; Song, JY; Yoon, JG	1
Abushanab, L; Alshamayleh, N; Anzueto, A; Arabiat, H; Diab, A; Haddad, G; Jaber, W; Khalil, B; Kufoof, N; Momani, D; Mughrabi, M; Mulhem, A; Obaidat, M; Odat, E; Ramadan, M; Wadi Al Ramahi, J; Zahran, A	1
Khajavian, S; Moradi, F; Rajabian, M; Ruzbahani, M; Shahbazi, F; Shahsavari, S; Shojaei, L; Tamasoki, N	1
Kanderi, T; Komanduri, S; Mansoora, Q; Shah, K; Shrimanker, I; Yumen, A	1
Bartoli, TA; Bevilacqua, N; D'Abramo, A; Di Rosa, E; Giancola, ML; Lepore, L; Maffongelli, G; Mariano, A; Nicastri, E; Palazzolo, C; Vulcano, A	1
Aguilar-Rivera, LR; Carrizales-Sepúlveda, EF; Gómez-Quiroz, RA; González-Aguirre, JE; Jiménez-Castillo, RA; Llantada-López, AR; Náñez-Terreros, H; Rendón-Ramírez, EJ	1
Chen, L; Du, X; Han, Y; Jian, Y; Xuan, J	1
Cardoso, L; Gonçalves, JR; Marques, R; Serra, P	1
Bauer, M; Kölsch, U; Krüger, R; Meisel, C; Unterwalder, N; von Bernuth, H; Wahn, V	1
Huang, Y; Jiao, Y; Jin, SY; Li, YS; Metersky, ML; Nie, XM; Wang, H; Yang, ZW	1
Rech, MA; Steuber, H; Williams, D	1
Dadras, O; Dadsetan, B; Heidari, H; Izadi, M; Jafari, S; Mazaheri, E; Najafi, Z; SeyedAlinaghi, S; Voltarelli, F	1
Chang, LW; Chang, YT; Cheng, SL; Chuang, YC; Hsu, MC; Perng, WC; Tsao, SM; Wu, RG	1
Funaishi, K; Hattori, N; Katsutani, S; Kawamoto, K; Matsumoto, N; Matsumoto, Y; Ohashi, N; Taniwaki, M; Yamasaki, M	1
Chopra, V; Conlon, A; Flanders, SA; Gandhi, T; Malani, AN; Vaughn, VM	1
Atic, A; Basic-Jukic, N; Kirincich, J; Sakic, Z	1
Kaufmann, M; Knabbe, C; Seibold, E; Splettstoesser, W; Weile, J	1
Carrión Valero, F; Monclou Garzón, E; Urbano Salcedo, A	1
Kalugin, VV; Kondrat'eva, TV; Makarevich, AM; Zaĭtsev, AA	1
Li, F; Liu, Y; Pu, C; Ren, X; Ren, Y; Sui, DJ; Sun, L; Sun, T; Wang, R; Yang, Z	1
Bulcun, E; Çimen, D; Ekici, A; Ekici, M; Güngör, Ö	1
Akata, K; Awaya, Y; Chojin, Y; Hara, K; Hata, R; Inoue, N; Ishimoto, H; Kato, K; Kawanami, T; Kawanami, Y; Mukae, H; Naito, K; Nishida, C; Noguchi, S; Obata, H; Oda, K; Ogoshi, T; Orihashi, T; Sasahara, Y; Shimabukuro, I; Shiraishi, T; Suzuki, Y; Tachiwada, T; Takaki, T; Taura, Y; Tokuyama, S; Tsuda, T; Uchimura, K; Yamasaki, K; Yatera, K; Yoshida, Y; Yoshii, C	1
Adhikary, R; Bhattacharyya, A; Bishayi, B; Mahanti, S; Majhi, A	1
Famularo, G; Gasbarrone, L; Pizzicannella, M	1
Baluya, D; Brown, D; Drusano, GL; Fikes, S; Jelliffe, R; Kurhanewicz, S; Liu, W; Louie, A; Neely, MN; Robbins, N; Schumitzky, A; VanGuilder, M	1
Duncan, R; Gilman, M; Gray, A; James, N	1
Sivasambu, B; Yogarajah, M	1
Cai, X; Cui, J; Ni, W; Wei, C	1
Bernad, I; Berroa, F; Gil, MP	1
Badari, MS; Elgendy, SG; Hassan, AT; Mohamed, AS	1
Frith, JA; Hostoffer, RW; Robertson, LM; Tcheurekdjian, H	1
Argemi, X; Hansmann, Y; Keller, N; Martin, A; Martin, M; Martin, T; Twizeyimana, E	1
Jiménez Gómez, M; Lindo Ricce, M; P Gisbert, J; Rodriguez-Batllori Arán, B; Santander, C	1
Fernández-Fernández, FJ	1
Bateman, AC; Clarridge, J; Garvin, K; Greenbaum, A; Grim, J; Liu, AW	1
Blasi, F; Centanni, S; Clerici, M; Garziano, M; Mantero, M; Trabattoni, D	1
Elias, N; Odeh, M; Sabetay, S; Sheikh-Ahmad, M; Slobodin, G; Weller, B; Zaygraikin, N	1
Attridge, RT; Fisher, A; Frei, CR; Jaso, TC; Makos, BR; Mody, SH; Mortensen, EM; Oramasionwu, CU; Raut, MK; Restrepo, MI; Ruiz, AD; Ruiz, JL; Schein, JR	1
Bi, R; Huang, G; Sun, P; Wang, J; Zhang, N; Zhang, X	1
Garber, SM; Miller, SM; Pound, MW	1
Fisher, AC; Grant, R; Gu, A; Mody, SH; Ng, D; Raut, M; Schein, J; Sengupta, A; Sheng Duh, M; Signorovitch, JE	1
Baek, YS; Cheong, MH; Durey, A; Lee, JS; Lee, K; Park, JS; Ryu, JS	1
Bester, AJ; Chang, LW; Chang, YT; Chung, DT; Ho, ML; Hsu, MC; Kasumba, J; King, CH; Mitha, IH; Perng, RP; van Rensburg, DJ; Wu, RG	1
Cohen, R; Grimprel, E	1
Dudley, MN; Griffith, DC; Lomovskaya, O; Sabet, M; Tarazi, Z; Tsivkovskii, R	1
Figueira-Coelho, J; Mendonça, P; Neta, J; Neves-Costa, J; Pereira, O; Picado, B	1
Guchev, IA; Iudenich, OV; Melekhina, EV	1
Dortdudak, S; Eroglu, E; Kocyigit, I; Oymak, O; Sipahioglu, M; Tokgoz, B; Unal, A; Utas, C; Yucel, HE	1
Bénard, MR; Kok, LM; van Arkel, ER	1
Bru, JP	1
Bahal, N; Frank, E; Freitag, S; Kahn, JB; Kinasewitz, G; Liu, J; Moran, GJ; Olson, WH; Oross, MP; Reichl, V; Tennenberg, A; Wiesinger, BA	1
Bellmann, R; Egger, P; Feistritzer, C; Joannidis, M; Pechlaner, C; Vogel, W; Wiedermann, CJ	1
Dunbar, LM; Habib, MP; Kahn, JB; Khashab, MM; Smith, LG; Tennenberg, AM; Wiesinger, BA; Wunderink, RG; Xiang, JX; Zadeikis, N	1
Alonso-Tarrés, C; Bastida, T; Campos, J; Cortés-Lletget, MC; de la Campa, AG; Pérez-Vázquez, M; Román, F; Tubau, F	1
Marrie, TJ	1
Hoepelman, I	1
Alvarez-Lerma, F; Bermejo, B; León, C; Olaechea, P; Palomar, M; Sanchez, M	1
Breen, JD; Camere, MA; D'Ignazio, J; Jorgensen, D; Lewis, DE	1
Shorr, AF; Tennenberg, AM; Wes Ely, E; Xiang, JX; Zadeikis, N	1
Burgmann, H; Hutschala, D; Jaksch, P; Mayer-Helm, BX; Müller, M; Skhirtladze, K; Tschernko, EM; Wisser, W; Wolner, E; Zuckermann, A	1
Díaz F, A; Pavié G, J; Prida C, JM; Saldías P, F	1
Blasi, F; Tarsia, P	1
Ascione, T; Esposito, S; Gaeta, GB; Ianniello, F; Leone, S; Noviello, S	1
Rizvi, AA; Wang, S	1
Akcay, A; Aydogan, T; Bozalan, R; Isik, A; Kanbay, M; Kaya, A; Uz, B	1
File, TM; Lynch, JP; Zhanel, GG	1
Arakaki, N; Shimoji, T; Tamaki, K; Tohyama, M	1
De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L	1
Arguedas, A; Blumer, JL; Bradley, JS; Melkote, R; Noel, GJ; Sáez-Llorens, X	1
Anderson, VR; Perry, CM	1
Dowzicky, M; Kuti, JL; Nicolau, DP	1
Hutschala, D; Kinstner, C; Mayer-Helm, BX; Müller, M; Skhirtladze, K; Tschernko, E; Wisser, W; Zeitlinger, M	1
Ambrose, PG; Nightingale, CH; Owens, RC; Quintiliani, R	1
Chuck, SK; Jung, R; Martin, SJ; Messick, CR; Meyer, JM; Pendland, SL	1
Fujita, A; Goya, T; Hirayama, S; Isaka, H; Koshiishi, Y; Miya, T; Ono, Y; Tanaka, R	1
Feagan, BG; Lau, CY; Marrie, TJ; Vandervoort, MK; Wheeler, SL; Wong, CJ	1
Elixhauser, A; Feagan, BG; Halpern, MT; Marrie, TJ; Palmer, CS; Rance, L; Zhan, C	1
Clark, LC; Davis, CW	1
Halley, HJ	1
Bagilet, D; Diab, M; Javkin, E; Kalbermatter, V	1
Milkovich, G	1
Feagan, BG	1
Carbon, C	1
Guinea, O; Noval Menéndez, J; Nuño Mateo, FJ; Suárez, M	1
Ackerman, BH; Cawley, MJ; Digwood-Lettieri, S; Guilday, RJ; Haith, LR; Patton, ML; Reilly, KJ	1
Busman, TA; Dattani, D; Devcich, KJ; Gotfried, MH; Notario, GF; Palmer, RN; Riffer, E	1

Reviews

9 review(s) available for levofloxacin and Experimental Lung Inflammation

Article	Year
Legionella micdadei Aquaticum Infection: a Case Report and Literature Review. Clinical laboratory, 2022, Apr-01, Volume: 68, Issue:4 Topics: Adult; Azithromycin; Erythromycin; Female; Humans; Legionella; Legionellaceae; Legionellosis; Levofloxacin; Male; Middle Aged; Pneumonia	2022
Clinical Benefits and Cost-Effectiveness of Moxifloxacin as Initial Treatment for Community-Acquired Pneumonia: A Meta-Analysis and Economic Evaluation. Clinical therapeutics, 2021, Volume: 43, Issue:11 Topics: Community-Acquired Infections; Cost-Benefit Analysis; Humans; Levofloxacin; Moxifloxacin; Pneumonia	2021
[New fluoroquinolones: levofloxacin, moxifloxacin and gatifloxacin]. Nederlands tijdschrift voor geneeskunde, 2004, Oct-23, Volume: 148, Issue:43 Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Pneumonia; Quinolines; Respiratory Tract Infections	2004
Value of short-course antimicrobial therapy in community-acquired pneumonia. International journal of antimicrobial agents, 2005, Volume: 26 Suppl 3 Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Microspheres; Ofloxacin; Pneumonia; Time Factors; Treatment Outcome	2005
Levofloxacin for the treatment of community-acquired pneumonia. Expert review of anti-infective therapy, 2006, Volume: 4, Issue:5 Topics: Community-Acquired Infections; Humans; Levofloxacin; Ofloxacin; Pneumonia	2006
Levofloxacin : a review of its use as a high-dose, short-course treatment for bacterial infection. Drugs, 2008, Volume: 68, Issue:4 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Community-Acquired Infections; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Ofloxacin; Pneumonia	2008
New generations of quinolones: with particular attention to levofloxacin. Connecticut medicine, 1997, Volume: 61, Issue:5 Topics: Anti-Infective Agents; Community-Acquired Infections; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Pneumonia; Quinolones	1997
Levofloxacin and sparfloxacin: new quinolone antibiotics. The Annals of pharmacotherapy, 1998, Volume: 32, Issue:3 Topics: Absorption; Anti-Infective Agents; Bronchitis; Drug Interactions; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Ofloxacin; Pneumonia; Quinolones; Sinusitis; Skin Diseases; Urinary Tract Infections	1998
Optimal treatment strategies for community-acquired pneumonia: high-risk patients (geriatric and with comorbidity). Chemotherapy, 2001, Volume: 47 Suppl 4 Topics: Age Factors; Aged; Anti-Infective Agents; Community-Acquired Infections; Comorbidity; Drug Resistance, Microbial; Female; Health Status Indicators; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia; Practice Guidelines as Topic; Risk Factors	2001

Trials

19 trial(s) available for levofloxacin and Experimental Lung Inflammation

Article	Year
Levofloxacin Versus Ceftriaxone and Azithromycin Combination in the Treatment of Community Acquired Pneumonia in Hospitalized Patients. Recent patents on anti-infective drug discovery, 2018, Volume: 13, Issue:3 Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Asia; Azithromycin; Ceftriaxone; Community-Acquired Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospitalization; Humans; Levofloxacin; Male; Middle Aged; Pneumonia; Prospective Studies; Treatment Outcome	2018
Integrated safety summary of phase II and III studies comparing oral nemonoxacin and levofloxacin in community-acquired pneumonia. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2019, Volume: 52, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Community-Acquired Infections; Double-Blind Method; Drug Combinations; Female; Fluoroquinolones; Humans; Levofloxacin; Lung Diseases; Male; Middle Aged; Pneumonia; Quinolones; Safety; South Africa; Taiwan; Treatment Outcome; Young Adult	2019
[Antibiotic therapy regimens for mild community-acquired pneumonia in patients with risk factors for ineffective treatment: clinical and economic comparisons]. Terapevticheskii arkhiv, 2013, Volume: 85, Issue:12 Topics: Adolescent; Adult; Anti-Bacterial Agents; Community-Acquired Infections; Female; Humans; Levofloxacin; Male; Middle Aged; Pneumonia; Risk Factors; Severity of Illness Index; Treatment Outcome; Young Adult	2013
Clinical efficacy and safety of moxifloxacin versus levofloxacin plus metronidazole for community-acquired pneumonia with aspiration factors. Chinese medical journal, 2014, Volume: 127, Issue:7 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Moxifloxacin; Pneumonia; Prospective Studies	2014
Immunomodulatory Effects of Levofloxacin on Patients with Pneumonia in Assiut University Hospitals. The Egyptian journal of immunology, 2015, Volume: 22, Issue:1 Topics: Anti-Bacterial Agents; Egypt; Female; Hospitals, University; Humans; Levofloxacin; Male; Pneumonia	2015
Immunomodulatory effects of pidotimod in adults with community-acquired pneumonia undergoing standard antibiotic therapy. Pulmonary pharmacology & therapeutics, 2017, Volume: 44 Topics: Anti-Bacterial Agents; Community-Acquired Infections; Female; Hospitalization; Humans; Immunity, Innate; Immunologic Factors; Levofloxacin; Male; Middle Aged; Pneumonia; Prospective Studies; Pyrrolidonecarboxylic Acid; Thiazolidines; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha	2017
Efficacy and safety of nemonoxacin versus levofloxacin for community-acquired pneumonia. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10 Topics: Adult; Anti-Bacterial Agents; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Quinolones; Treatment Outcome	2010
A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia. Clinical therapeutics, 2002, Volume: 24, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Azithromycin; Ceftriaxone; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Severity of Illness Index	2002
High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Sep-15, Volume: 37, Issue:6 Topics: Adult; Anti-Infective Agents; Community-Acquired Infections; Double-Blind Method; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Pneumonia; Treatment Outcome	2003
Experience with levofloxacin in a critical pathway for the treatment of community-acquired pneumonia. Chemotherapy, 2004, Volume: 50 Suppl 1 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ambulatory Care; Anti-Infective Agents; Azithromycin; Cefuroxime; Community-Acquired Infections; Critical Pathways; Drug Therapy, Combination; Female; Humans; Levofloxacin; Longitudinal Studies; Male; Middle Aged; Ofloxacin; Oxygen Inhalation Therapy; Pneumococcal Infections; Pneumonia; Pneumonia, Bacterial; Treatment Outcome	2004
Levofloxacin in the treatment of pneumonia in intensive care unit patients. Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:6 Topics: Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Critical Illness; Cross Infection; Drug Administration Schedule; Female; Humans; Intensive Care Units; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Treatment Outcome	2004
Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired Pneumonia in adults. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:10 Topics: Adult; Aged; Anti-Bacterial Agents; Azithromycin; Chemistry, Pharmaceutical; Community-Acquired Infections; Double-Blind Method; Female; Humans; Incidence; Levofloxacin; Male; Microspheres; Middle Aged; Ofloxacin; Outpatients; Pneumonia; Serologic Tests; Time Factors; Treatment Outcome	2005
A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged > or =65 years with community-acquired pneumonia. Clinical therapeutics, 2005, Volume: 27, Issue:8 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Community-Acquired Infections; Double-Blind Method; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Multicenter Studies as Topic; Ofloxacin; Pneumonia; Randomized Controlled Trials as Topic; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2005
Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia. The Pediatric infectious disease journal, 2007, Volume: 26, Issue:10 Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Ofloxacin; Pneumonia; Treatment Outcome	2007
A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA, 2000, Feb-09, Volume: 283, Issue:6 Topics: Aged; Anti-Infective Agents; Canada; Community-Acquired Infections; Critical Pathways; Female; Hospitalization; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Outcome Assessment, Health Care; Pneumonia; Sickness Impact Profile; Statistics, Nonparametric	2000
Economic assessment of the community-acquired pneumonia intervention trial employing levofloxacin. Clinical therapeutics, 2000, Volume: 22, Issue:2 Topics: Aged; Anti-Infective Agents; Canada; Cluster Analysis; Community-Acquired Infections; Critical Pathways; Delivery of Health Care; Female; Humans; Length of Stay; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Severity of Illness Index	2000
[Oral levofloxacin versus intravenous ceftriaxone and amoxicillin/clavulanic acid in the treatment of community-acquired pneumonia that requires hospitalization]. Medicina clinica, 2000, Nov-04, Volume: 115, Issue:15 Topics: Administration, Oral; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Prospective Studies	2000
A controlled trial of a critical pathway for treating community-acquired pneumonia: the CAPITAL study. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. Pharmacotherapy, 2001, Volume: 21, Issue:7 Pt 2 Topics: Administration, Oral; Adult; Anti-Infective Agents; Canada; Community-Acquired Infections; Critical Pathways; Hospitalization; Humans; Injections, Intravenous; Length of Stay; Levofloxacin; Ofloxacin; Pneumonia; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome	2001
A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia. Clinical therapeutics, 2002, Volume: 24, Issue:5 Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Treatment Outcome	2002

Other Studies

64 other study(ies) available for levofloxacin and Experimental Lung Inflammation

Article	Year
Pharmacodynamics of levofloxacin in a murine pneumonia model of Pseudomonas aeruginosa infection: determination of epithelial lining fluid targets. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Epithelium; Female; Levofloxacin; Mice; Ofloxacin; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections	2009
Pharmacodynamic profile of tigecycline against methicillin-resistant Staphylococcus aureus in an experimental pneumonia model. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Animals; Anti-Bacterial Agents; Female; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Minocycline; Pneumonia; Staphylococcal Infections; Tigecycline	2009
Economic Evaluation of Nemonoxacin, Moxifloxacin and Levofloxacin in the Treatment of Early Community-Acquired Pneumonia with Possible Pulmonary Tuberculosis. International journal of environmental research and public health, 2022, 04-15, Volume: 19, Issue:8 Topics: Anti-Bacterial Agents; Community-Acquired Infections; Cost-Benefit Analysis; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; Pneumonia; Quinolones; Randomized Controlled Trials as Topic; Tuberculosis, Pulmonary	2022
Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance, and clinical outcomes. PloS one, 2022, Volume: 17, Issue:6 Topics: Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Healthcare-Associated Pneumonia; Hospitals; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Pneumonia; Pseudomonas aeruginosa; Retrospective Studies; Risk Factors	2022
Speed of recovery in adult patients with community-acquired pneumonia; moxifloxacin versus levofloxacin. Journal of infection in developing countries, 2018, 10-31, Volume: 12, Issue:10 Topics: Adult; Anti-Bacterial Agents; Community-Acquired Infections; Female; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Pneumonia; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2018
Analysis of QTc Interval during Levofloxacin Prescription in Cardiac Patients with Pneumonia. Current drug safety, 2020, Volume: 15, Issue:2 Topics: Adult; Aged; Cross-Sectional Studies; Electrocardiography; Female; Humans; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Pneumonia; Torsades de Pointes	2020
Stenotrophomonas maltophilia: An Emerging Pathogen of the Respiratory Tract. The American journal of case reports, 2020, May-25, Volume: 21 Topics: Aged; Anti-Bacterial Agents; Fatal Outcome; Female; Gram-Negative Bacterial Infections; Heart Arrest; Humans; Levofloxacin; Opportunistic Infections; Pneumonia; Sepsis; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination	2020
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2020, Volume: 25, Issue:30 Topics: Administration, Intravenous; Adult; Anti-Infective Agents, Urinary; Antigens, Bacterial; Cough; Fever; Headache; Humans; Legionella; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Male; Pneumonia; Treatment Outcome	2020
A case of round pneumonia due to Enterobacter hormaechei: the need for a standardized diagnosis and treatment approach in adults. Revista do Instituto de Medicina Tropical de Sao Paulo, 2021, Volume: 63 Topics: Adult; Aged; Anti-Bacterial Agents; Cough; Dyspnea; Enterobacter; Enterobacteriaceae Infections; Humans; Levofloxacin; Lung; Male; Pneumonia; Sputum; Treatment Outcome	2021
Acute fibrinous and organising pneumonia. BMJ case reports, 2017, Sep-07, Volume: 2017 Topics: Anti-Bacterial Agents; Biopsy; Community-Acquired Infections; Cryptogenic Organizing Pneumonia; Diagnosis, Differential; Female; Fever; Fibrin; Glucocorticoids; Humans; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Lung; Lung Diseases, Interstitial; Middle Aged; Pneumonia; Prednisolone; Radiography; Rare Diseases; Tomography, X-Ray Computed; Treatment Outcome	2017
Antibiotic Prophylaxis, Immunoglobulin Substitution and Supportive Measures Prevent Infections in MECP2 Duplication Syndrome. The Pediatric infectious disease journal, 2018, Volume: 37, Issue:5 Topics: Administration, Intravenous; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Humans; IgA Deficiency; IgG Deficiency; Immunoglobulin M; Immunoglobulins; Levofloxacin; Male; Mental Retardation, X-Linked; Pneumonia; Sepsis; Young Adult	2018
Initial empiric antibiotic therapy for community-acquired pneumonia in Chinese hospitals. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24, Issue:6 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Community-Acquired Infections; Female; Fluoroquinolones; Hospital Mortality; Hospitalization; Humans; Length of Stay; Levofloxacin; Logistic Models; Male; Middle Aged; Pneumonia; Sex Factors; Treatment Failure; Young Adult	2018
Leave the levofloxacin? A case report of levofloxacin-induced psychosis. The American journal of emergency medicine, 2018, Volume: 36, Issue:8 Topics: Aged; Anti-Infective Agents; Community-Acquired Infections; Female; Humans; Levofloxacin; Pneumonia; Psychoses, Substance-Induced	2018
Acquired factor V inhibitor after antibiotic treatment in a patient with pneumonia: a case report. Annals of hematology, 2019, Volume: 98, Issue:8 Topics: Aged; Anti-Bacterial Agents; Antibody Specificity; Antifungal Agents; Autoantibodies; Autoimmune Diseases; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Substitution; Drug Therapy, Combination; Factor V; Factor V Deficiency; Fluoroquinolones; Humans; Levofloxacin; Male; Meropenem; Micafungin; Partial Thromboplastin Time; Pneumonia; Prothrombin Time	2019
The Association of Antibiotic Stewardship With Fluoroquinolone Prescribing in Michigan Hospitals: A Multi-hospital Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 09-27, Volume: 69, Issue:8 Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Ciprofloxacin; Clostridium Infections; Cohort Studies; Drug Prescriptions; Drug Resistance, Bacterial; Female; Fluoroquinolones; Hospitals; Humans; Levofloxacin; Male; Michigan; Moxifloxacin; Pneumonia; Retrospective Studies; Risk; Surveys and Questionnaires	2019
Community Acquired Legionnaire's Disease in a Kidney Transplant Patient. Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki), 2018, Dec-01, Volume: 39, Issue:2-3 Topics: Anti-Bacterial Agents; Community-Acquired Infections; Critical Care; Humans; Immunocompromised Host; Kidney Transplantation; Legionellosis; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pneumonia; Radiography, Thoracic; Treatment Outcome	2018
Treatment of tularemia in patient with chronic graft-versus-host disease. Emerging infectious diseases, 2013, Volume: 19, Issue:5 Topics: Anti-Bacterial Agents; Chronic Disease; Doxycycline; Francisella tularensis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Tularemia	2013
Pulmonary eosinophilia caused by testosterone cypionate. Archivos de bronconeumologia, 2013, Volume: 49, Issue:11 Topics: Adult; Alveolar Epithelial Cells; Anabolic Agents; Antipyretics; Bronchoalveolar Lavage Fluid; Diagnostic Errors; Dietary Supplements; Dyspnea; Hemoptysis; Humans; Hyperplasia; Levofloxacin; Male; Oxygen Inhalation Therapy; Performance-Enhancing Substances; Pneumonia; Pulmonary Eosinophilia; Testosterone	2013
Case of round pneumonia: pulmonary infarct and a rare situation that is similar with the lung cancer. The clinical respiratory journal, 2015, Volume: 9, Issue:4 Topics: Diagnosis, Differential; Fluoroquinolones; Humans; Levofloxacin; Lung Neoplasms; Male; Middle Aged; Moxifloxacin; Pneumonia; Pulmonary Infarction; Radiography, Thoracic; Treatment Outcome; Young Adult	2015
[Efficacy and safety of levofloxacin in patients with nursing and healthcare-associated pneumonia]. The Japanese journal of antibiotics, 2014, Volume: 67, Issue:1 Topics: Anti-Bacterial Agents; Cross Infection; Female; Humans; Japan; Levofloxacin; Male; Ofloxacin; Pneumonia; Prospective Studies	2014
Levofloxacin-ceftriaxone combination attenuates lung inflammation in a mouse model of bacteremic pneumonia caused by multidrug-resistant Streptococcus pneumoniae via inhibition of cytolytic activities of pneumolysin and autolysin. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9 Topics: Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Bronchoalveolar Lavage Fluid; Ceftriaxone; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Levofloxacin; Male; Mice; Mice, Inbred BALB C; N-Acetylmuramoyl-L-alanine Amidase; Pneumococcal Infections; Pneumonia; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Streptolysins; Virulence; Virulence Factors	2014
Levofloxacin and seizures: what risk for elderly adults? Journal of the American Geriatrics Society, 2014, Volume: 62, Issue:10 Topics: Aged, 80 and over; Anti-Bacterial Agents; Female; Humans; Levofloxacin; Pneumonia; Seizures	2014
Combination treatment with meropenem plus levofloxacin is synergistic against Pseudomonas aeruginosa infection in a murine model of pneumonia. The Journal of infectious diseases, 2015, Apr-15, Volume: 211, Issue:8 Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Levofloxacin; Meropenem; Mice; Microbial Sensitivity Tests; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	2015
A novel cause of community-acquired pneumonia in a young immunocompetent host. The clinical respiratory journal, 2016, Volume: 10, Issue:5 Topics: Actinomycetales Infections; Adult; Bronchoalveolar Lavage Fluid; Community-Acquired Infections; Diagnosis, Differential; Gordonia Bacterium; Humans; Immunocompetence; Levofloxacin; Male; Pneumonia; Tomography, X-Ray Computed; Treatment Outcome	2016
Legionnaires disease presenting as acute kidney injury in the absence of pneumonia. BMJ case reports, 2015, Feb-17, Volume: 2015 Topics: Acute Kidney Injury; Anti-Bacterial Agents; Diagnosis, Differential; Humans; Legionnaires' Disease; Levofloxacin; Lung; Male; Middle Aged; Pneumonia; Radiography	2015
A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia. Infectious diseases (London, England), 2015, Volume: 47, Issue:12 Topics: Adult; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cross Infection; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Minocycline; Monte Carlo Method; Moxifloxacin; Pneumonia; Sputum; Stenotrophomonas maltophilia; Tigecycline	2015
[Chronic hand infection]. Enfermedades infecciosas y microbiologia clinica, 2017, Volume: 35, Issue:2 Topics: Amputation, Surgical; Animals; Anti-Bacterial Agents; Delayed Diagnosis; Disease Susceptibility; Fingers; Fishes; Hand Dermatoses; Humans; Levofloxacin; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Pneumonia; Postoperative Complications; Trimethoprim, Sulfamethoxazole Drug Combination	2017
Possible mast cell activation syndrome in a patient undergoing long-term hemodialysis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2016, Volume: 116, Issue:6 Topics: Aged; Amlodipine; Anaphylaxis; Carbazoles; Carvedilol; Community-Acquired Infections; Deglutition Disorders; Epinephrine; Female; Humans; Kidney Failure, Chronic; Levofloxacin; Mastocytosis; Pneumonia; Propanolamines; Renal Dialysis; Tryptases	2016
A non-fatal pneumonia due to Legionella longbeachae in a patient with systemic lupus erythematosus. Lupus, 2016, Volume: 25, Issue:13 Topics: Adult; Female; Humans; Legionella longbeachae; Legionellosis; Levofloxacin; Lupus Erythematosus, Systemic; Pneumonia; Spiramycin; Treatment Outcome	2016
Non-responsive coeliac disease: Coeliac crisis vs. refractory coeliac disease with response to corticosteroids. Gastroenterologia y hepatologia, 2017, Volume: 40, Issue:8 Topics: Autoantibodies; Autoantigens; Bipolar Disorder; Celiac Disease; Diarrhea; Diet, Gluten-Free; Dissociative Disorders; Drug Therapy, Combination; Female; GTP-Binding Proteins; Humans; Immunoglobulin A; Levofloxacin; Linezolid; Methylprednisolone; Middle Aged; Pneumonia; Protein Glutamine gamma Glutamyltransferase 2; Protein-Energy Malnutrition; Respiratory Insufficiency; Transglutaminases	2017
Prolonged P wave with biphasic morphology in the inferior leads. European journal of internal medicine, 2017, Volume: 39 Topics: Aged; Anti-Bacterial Agents; Arrhythmias, Cardiac; Electrocardiography; Female; Heart Conduction System; Humans; Levofloxacin; Moraxella catarrhalis; Pneumonia	2017
Cutaneous phaeohyphomycosis in a hematopoietic stem cell transplant patient caused by Alternaria rosae: First case report. Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:3 Topics: Acute Kidney Injury; Acyclovir; Aged; Alternaria; Alternariosis; Antibiotic Prophylaxis; Antifungal Agents; Drug Therapy, Combination; Fatal Outcome; Graft vs Host Disease; Hand; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Levofloxacin; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Paranasal Sinuses; Phaeohyphomycosis; Pneumonia; Prednisone; Primary Myelofibrosis; Respiratory Insufficiency; Spores, Fungal; Transplantation, Homologous; Triazoles; Voriconazole	2017
Levofloxacin-induced delirium. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2009, Volume: 30, Issue:2 Topics: Age Factors; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Brain; Clarithromycin; Confusion; Delirium; Ertapenem; Hallucinations; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia; Risk Factors; Sex Factors; Time Factors; Withholding Treatment	2009
Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study. Current medical research and opinion, 2009, Volume: 25, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Community-Acquired Infections; Drug Therapy, Combination; Female; Health Resources; Humans; Least-Squares Analysis; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Practice Guidelines as Topic; Societies, Medical; United States	2009
Targeted delivery of levofloxacin-liposomes for the treatment of pulmonary inflammation. Journal of drug targeting, 2009, Volume: 17, Issue:5 Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Chemistry, Pharmaceutical; Female; Levofloxacin; Liposomes; Mice; Ofloxacin; Pneumonia; Rabbits; Solubility; Tissue Distribution	2009
Hypoglycemia associated with the use of levofloxacin. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2009, Jun-01, Volume: 66, Issue:11 Topics: Anti-Bacterial Agents; Community-Acquired Infections; Diabetes Mellitus, Type 2; Drug Interactions; Glipizide; Humans; Hypoglycemia; Hypoglycemic Agents; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia	2009
Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin. Current medical research and opinion, 2010, Volume: 26, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Ambulatory Care; Anti-Infective Agents; Aza Compounds; Community-Acquired Infections; Costs and Cost Analysis; Female; Fluoroquinolones; Hospitalization; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Outpatients; Pneumonia; Quinolines; Young Adult	2010
Levofloxacin-induced Achilles tendinitis in a young adult in the absence of predisposing conditions. Yonsei medical journal, 2010, Volume: 51, Issue:3 Topics: Achilles Tendon; Adult; Anti-Bacterial Agents; Community-Acquired Infections; Disease Susceptibility; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia; Tendinopathy; Young Adult	2010
[Levofloxacin in children]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2010, Volume: 17 Suppl 4 Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Child; Community-Acquired Infections; Humans; Levofloxacin; Mycoplasma pneumoniae; Ofloxacin; Otitis Media; Pneumococcal Infections; Pneumonia; Sinusitis; Staphylococcus aureus; Streptococcus pneumoniae	2010
Levofloxacin reduces inflammatory cytokine levels in human bronchial epithelia cells: implications for aerosol MP-376 (levofloxacin solution for inhalation) treatment of chronic pulmonary infections. FEMS immunology and medical microbiology, 2011, Volume: 61, Issue:2 Topics: Administration, Inhalation; Aerosols; Anti-Inflammatory Agents; Cell Line; Chronic Disease; Epithelial Cells; Gene Expression Profiling; Humans; Interleukin-6; Interleukin-8; Levofloxacin; Ofloxacin; Pneumonia; Tobramycin	2011
Acute hepatitis associated with the use of levofloxacin. Clinical therapeutics, 2010, Volume: 32, Issue:10 Topics: Acute Disease; Aged; Anti-Bacterial Agents; Biopsy, Needle; Chemical and Drug Induced Liver Injury; Humans; Levofloxacin; Liver Function Tests; Male; Ofloxacin; Pneumonia; Treatment Outcome	2010
[Levofloxacin. expediency of high-dose regimens in therapy of lower respiratory tract infections]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2011, Volume: 56, Issue:3-4 Topics: Community-Acquired Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Ofloxacin; Pneumonia; Pulmonary Disease, Chronic Obstructive	2011
Levofloxacin-induced delirium: is it a dangerous drug in patients with renal dysfunction? Renal failure, 2012, Volume: 34, Issue:5 Topics: Anti-Bacterial Agents; Delirium; Follow-Up Studies; Humans; Levofloxacin; Magnetic Resonance Imaging; Male; Middle Aged; Ofloxacin; Pneumonia; Renal Insufficiency; Tomography, X-Ray Computed	2012
[Bilateral Achilles tendon rupture following levofloxacin and glucocorticoid use]. Nederlands tijdschrift voor geneeskunde, 2012, Volume: 156, Issue:13 Topics: Achilles Tendon; Aged; Anti-Infective Agents; Casts, Surgical; Female; Glucocorticoids; Humans; Levofloxacin; Ofloxacin; Pneumonia; Rupture	2012
[Update on the role of levofloxacin in the management of acute community-acquired pneumonia]. Presse medicale (Paris, France : 1983), 2002, Jun-15, Volume: 31, Issue:21 Pt 2 Topics: Acute Disease; Anti-Infective Agents; Bacteremia; Community-Acquired Infections; Humans; Levofloxacin; Ofloxacin; Pneumonia; Randomized Controlled Trials as Topic; Treatment Outcome	2002
Moxifloxacin: new preparation. A me-too with more cardiac risks. Prescrire international, 2002, Volume: 11, Issue:62 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Approval; Fluoroquinolones; France; Humans; Levofloxacin; Long QT Syndrome; Ofloxacin; Pneumonia	2002
Levofloxacin elimination during albumin dialysis. The International journal of artificial organs, 2003, Volume: 26, Issue:4 Topics: Adult; Albumins; Anti-Infective Agents; Crigler-Najjar Syndrome; Dialysis; Female; Humans; Levofloxacin; Ofloxacin; Pneumonia	2003
Levofloxacin treatment failure in Haemophilus influenzae pneumonia. Emerging infectious diseases, 2003, Volume: 9, Issue:11 Topics: Aged; Anti-Infective Agents; Community-Acquired Infections; DNA Gyrase; Electrophoresis, Gel, Pulsed-Field; Fatal Outcome; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Molecular Sequence Data; Ofloxacin; Pneumonia; Treatment Failure	2003
In vivo measurement of levofloxacin penetration into lung tissue after cardiac surgery. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:12 Topics: Aged; Anti-Infective Agents; Area Under Curve; Coronary Artery Bypass; Dose-Response Relationship, Drug; Humans; Levofloxacin; Lung; Middle Aged; Ofloxacin; Pneumonia; Pseudomonas Infections	2005
[Assessment of the management of community-acquired pneumonia in adults outpatients]. Revista medica de Chile, 2005, Volume: 133, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amoxicillin; Anti-Bacterial Agents; Chi-Square Distribution; Clarithromycin; Community-Acquired Infections; Emergencies; Female; Frail Elderly; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Prospective Studies; Treatment Failure	2005
Clinical efficacy and tolerability of levofloxacin in patients with liver disease: a prospective, non comparative, observational study. Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:1 Topics: Administration, Oral; Anti-Bacterial Agents; Chronic Disease; Drug Tolerance; Female; Humans; Levofloxacin; Liver Diseases; Male; Middle Aged; Ofloxacin; Peritonitis; Pneumonia; Prospective Studies; Urinary Tract Infections	2006
Levofloxacin-induced hypoglycemia in a nondiabetic patient. The American journal of the medical sciences, 2006, Volume: 331, Issue:6 Topics: Aged; Anti-Bacterial Agents; Coronary Artery Bypass; Female; Glucagon; Glucose; Humans; Hypoglycemia; Infusions, Intravenous; Insulin; Insulin Secretion; Insulin-Secreting Cells; Levofloxacin; Ofloxacin; Pneumonia	2006
A Rare but serious side effect of Levofloxacin: hypoglycemia in a geriatric patient. Diabetes care, 2006, Volume: 29, Issue:7 Topics: Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemia; Levofloxacin; Middle Aged; Ofloxacin; Pneumonia; Urinary Tract Infections	2006
[A case of drug-induced pneumonitis due to levofloxacin and kampo medicine]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2006, Volume: 44, Issue:12 Topics: Anti-Inflammatory Agents, Non-Steroidal; Drugs, Chinese Herbal; Female; Humans; Levofloxacin; Medicine, Kampo; Middle Aged; Ofloxacin; Pneumonia; Sinusitis	2006
In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections. BMC infectious diseases, 2007, Sep-21, Volume: 7 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pneumonia; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin	2007
A pharmacodynamic simulation to assess tigecycline efficacy for hospital-acquired pneumonia compared with other common intravenous antibiotics. Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:1 Topics: Anti-Bacterial Agents; Cross Infection; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Models, Biological; Monte Carlo Method; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Tigecycline	2008
The impact of perioperative atelectasis on antibiotic penetration into lung tissue: an in vivo microdialysis study. Intensive care medicine, 2008, Volume: 34, Issue:10 Topics: Adult; Aged; Anti-Bacterial Agents; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Humans; Infusions, Intravenous; Intensive Care Units; Levofloxacin; Microdialysis; Middle Aged; Ofloxacin; Pneumonia; Postoperative Care; Pulmonary Atelectasis	2008
Sparfloxacin and levofloxacin. The Medical letter on drugs and therapeutics, 1997, Apr-25, Volume: 39, Issue:999 Topics: Administration, Oral; Anti-Infective Agents; Bronchitis; Chronic Disease; Clinical Trials as Topic; Drug Eruptions; Fluoroquinolones; Gastrointestinal Diseases; Humans; Levofloxacin; Ofloxacin; Photosensitivity Disorders; Pneumonia; Quinolones	1997
[Levofloxacin concentrations in serum, sputum and lung tissue: evaluation of its efficacy according to breakpoint]. The Japanese journal of antibiotics, 1999, Volume: 52, Issue:11 Topics: Adult; Aged; Chronic Disease; Female; Humans; Levofloxacin; Lung; Male; Middle Aged; Ofloxacin; Pneumonia; Respiratory Tract Infections; Saliva; Time Factors	1999
Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pneumonia. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2000, Nov-15, Volume: 57 Suppl 3 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Community-Acquired Infections; Costs and Cost Analysis; Diagnosis-Related Groups; Drug Costs; Female; Hospitalization; Humans; Injections, Intravenous; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pneumonia; Practice Guidelines as Topic; Retrospective Studies; Treatment Outcome	2000
Approaches to drug therapy, formulary, and pathway management in a large community hospital. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2000, Nov-15, Volume: 57 Suppl 3 Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Community-Acquired Infections; Cost-Benefit Analysis; Critical Pathways; Disease Management; Drug Costs; Drug Therapy, Computer-Assisted; Formularies, Hospital as Topic; Hospitals, Community; Humans; Indiana; Injections, Intravenous; Length of Stay; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pharmacy Service, Hospital; Pneumonia; Seasons; Treatment Outcome	2000
Intravenous-to-oral transition therapy in community-acquired pneumonia: the INOVA Health System experience. Pharmacotherapy, 2001, Volume: 21, Issue:7 Pt 2 Topics: Administration, Oral; Aged; Anti-Infective Agents; APACHE; Ciprofloxacin; Community-Acquired Infections; Cost-Benefit Analysis; Drug Utilization; Female; Hospitalization; Humans; Injections, Intravenous; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Virginia	2001
[Achilles pain and functional impotence in a patient with chronic obstructive pulmonary disease with pneumonia. Tendon rupture caused by levofloxacin]. Revista clinica espanola, 2001, Volume: 201, Issue:9 Topics: Achilles Tendon; Aged; Anti-Infective Agents; Humans; Levofloxacin; Male; Ofloxacin; Pain; Pneumonia; Pulmonary Disease, Chronic Obstructive; Rupture	2001
Levofloxacin-induced toxic epidermal necrolysis in an elderly patient. Pharmacotherapy, 2002, Volume: 22, Issue:6 Topics: Aged; Anti-Infective Agents; Community-Acquired Infections; Female; Fluid Therapy; Humans; Levofloxacin; Ofloxacin; Pneumonia; Pulmonary Disease, Chronic Obstructive; Skin; Stevens-Johnson Syndrome	2002